Siga Technologies Inc financial data

Symbol
SIGA on Nasdaq
Industry
Pharmaceutical Preparations
Location
31 East 62 Nd Street, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
SIGA PHARMACEUTICALS INC (to 5/25/2000)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 477 % -32.9%
Quick Ratio 142 % -35.3%
Debt-to-equity 26.7 % +50%
Return On Equity 49.1 %
Return On Assets 38.7 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 71.4M shares +0.44%
Common Stock, Shares, Outstanding 71.4M shares +0.39%
Entity Public Float 231M USD -58%
Common Stock, Value, Issued 7.14K USD +0.39%
Weighted Average Number of Shares Outstanding, Basic 71.4M shares +0.4%
Weighted Average Number of Shares Outstanding, Diluted 71.8M shares +0.96%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 174M USD +399%
Research and Development Expense 11.6M USD -42.7%
Costs and Expenses 69.2M USD +54.9%
Operating Income (Loss) 105M USD
Nonoperating Income (Expense) 8.79M USD +122%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 110M USD
Income Tax Expense (Benefit) 24.6M USD
Net Income (Loss) Attributable to Parent 85.7M USD
Earnings Per Share, Basic 1.2 USD/shares
Earnings Per Share, Diluted 1.2 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 99.3M USD +39.6%
Accounts Receivable, after Allowance for Credit Loss, Current 12.1M USD +50.2%
Inventory, Net 62M USD -4.51%
Assets, Current 181M USD +23.8%
Deferred Income Tax Assets, Net 12.1M USD +53.3%
Property, Plant and Equipment, Net 1.41M USD -3.95%
Goodwill 898K USD 0%
Other Assets, Noncurrent 254K USD -88.2%
Assets 195M USD +23.3%
Accounts Payable, Current 1.26M USD +123%
Accrued Liabilities, Current 7.18M USD -76.2%
Contract with Customer, Liability, Current 13.7M USD -37.3%
Liabilities, Current 22.3M USD -27.5%
Operating Lease, Liability, Noncurrent 1M USD
Liabilities 25.9M USD -24.3%
Retained Earnings (Accumulated Deficit) -68.6M USD +38.3%
Stockholders' Equity Attributable to Parent 169M USD +36.5%
Liabilities and Equity 195M USD +23.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.12M USD -125%
Net Cash Provided by (Used in) Financing Activities -159K USD +97.9%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 600M shares 0%
Common Stock, Shares, Issued 71.4M shares +0.39%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 99.3M USD +39.6%
Deferred Tax Assets, Valuation Allowance 944K USD -4.25%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 12.5M USD +60.5%
Operating Lease, Liability 1.51M USD -8.17%
Lessee, Operating Lease, Liability, to be Paid 1.65M USD -7.03%
Property, Plant and Equipment, Gross 7.34M USD +6.19%
Operating Lease, Liability, Current 535K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 686K USD +68.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 683K USD +0.68%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +110%
Deferred Income Tax Expense (Benefit) 36.5K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 142K USD +7.13%
Lessee, Operating Lease, Liability, to be Paid, Year Three 166K USD -59.5%
Deferred Tax Assets, Operating Loss Carryforwards 1.19M USD -4.25%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 5.08M USD -0.43%
Lessee, Operating Lease, Liability, to be Paid, Year Four 410K USD 0%
Operating Lease, Payments 700K USD +16.7%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 138K USD +5.61%
Deferred Tax Assets, Net of Valuation Allowance 11.5M USD +69.9%